ATE371671T1 - Rekombinantes allergen, seine fragmente und die damit korrespondierenden dna-moleküle, vektoren, und diese dna-moleküle enthaltenden wirte, und dignostische und therapeutische verwendungen besagter allergene und fragmente - Google Patents

Rekombinantes allergen, seine fragmente und die damit korrespondierenden dna-moleküle, vektoren, und diese dna-moleküle enthaltenden wirte, und dignostische und therapeutische verwendungen besagter allergene und fragmente

Info

Publication number
ATE371671T1
ATE371671T1 AT95922855T AT95922855T ATE371671T1 AT E371671 T1 ATE371671 T1 AT E371671T1 AT 95922855 T AT95922855 T AT 95922855T AT 95922855 T AT95922855 T AT 95922855T AT E371671 T1 ATE371671 T1 AT E371671T1
Authority
AT
Austria
Prior art keywords
fragments
dna molecules
nucleotide sequence
dignostic
allergens
Prior art date
Application number
AT95922855T
Other languages
English (en)
Inventor
Tanja Ball
Susanne Vrtala
Wolfgang Sperr
Peter Valent
Markus Susani
Dietrich Kraft
Rudolf Valenta
Sylvia Laffer
Original Assignee
Phadia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia Ab filed Critical Phadia Ab
Application granted granted Critical
Publication of ATE371671T1 publication Critical patent/ATE371671T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95922855T 1994-06-14 1995-06-14 Rekombinantes allergen, seine fragmente und die damit korrespondierenden dna-moleküle, vektoren, und diese dna-moleküle enthaltenden wirte, und dignostische und therapeutische verwendungen besagter allergene und fragmente ATE371671T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402089A SE9402089D0 (sv) 1994-06-14 1994-06-14 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments

Publications (1)

Publication Number Publication Date
ATE371671T1 true ATE371671T1 (de) 2007-09-15

Family

ID=20394387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95922855T ATE371671T1 (de) 1994-06-14 1995-06-14 Rekombinantes allergen, seine fragmente und die damit korrespondierenden dna-moleküle, vektoren, und diese dna-moleküle enthaltenden wirte, und dignostische und therapeutische verwendungen besagter allergene und fragmente

Country Status (9)

Country Link
US (3) US6008340A (de)
EP (1) EP0763059B2 (de)
JP (1) JPH10501417A (de)
AT (1) ATE371671T1 (de)
AU (1) AU2759895A (de)
DE (1) DE69535587T3 (de)
ES (1) ES2293641T5 (de)
SE (1) SE9402089D0 (de)
WO (1) WO1995034578A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
SE9703531D0 (sv) * 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2319437C (en) 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
AU2065801A (en) * 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
US8153414B2 (en) * 2000-04-06 2012-04-10 Allertein Therapeutics, Llc Microbial delivery system
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
EP1221317A1 (de) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Impfstoffe, die hybride Polypeptide mit mindestens zwei verschiedenen Allergenen enthalten
SE0200946D0 (sv) * 2002-03-27 2002-03-27 Pharmacia Diagnostics Ab Novel Allergen
ATE503494T1 (de) * 2003-06-23 2011-04-15 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
ATE524561T1 (de) * 2004-04-06 2011-09-15 Sinai School Medicine Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
AT503296B1 (de) * 2006-05-03 2007-09-15 Biomay Ag Protein-allergen-derivat
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
AU2008316301B2 (en) * 2007-10-22 2014-07-24 The University Of Queensland Immunogenic protein Pas n 1 from bahia grass pollen
US20130004528A1 (en) * 2010-02-26 2013-01-03 Benaroya Research Institute Direct analysis of antigen-specific immune response
WO2012148549A1 (en) 2011-02-25 2012-11-01 Benaroya Research Institute Detection of an immune response
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659801B2 (en) * 1990-08-17 1995-06-01 University Of Melbourne, The Ryegrass pollen allergen
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US5710126A (en) 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
FI954269L (fi) * 1993-03-12 1995-09-12 Immunologic Pharma Corp Raiheinäsiitepölyallergeenin T-soluepitoopit
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
US6300482B1 (en) 1995-01-03 2001-10-09 Max-Flanck-Gesellschaft Zuer For{Overscore (D)}Erung Der MDKI, a novel receptor tyrosine kinase
JP3073684B2 (ja) * 1996-01-30 2000-08-07 鹿島建設株式会社 ターミナルレヒート空調システムの制御装置
US6300487B1 (en) 1996-03-19 2001-10-09 Cell Therapuetics, Inc. Mammalian lysophosphatidic acid acyltransferase
US6303302B1 (en) 1997-11-19 2001-10-16 The Whitehead Institute For Biomedical Research Regulation of fungal gene expression
US6146830A (en) 1998-09-23 2000-11-14 Rosetta Inpharmatics, Inc. Method for determining the presence of a number of primary targets of a drug

Also Published As

Publication number Publication date
DE69535587T2 (de) 2008-05-21
DE69535587T3 (de) 2011-02-24
EP0763059A1 (de) 1997-03-19
ES2293641T5 (es) 2010-12-13
US20020052490A1 (en) 2002-05-02
WO1995034578A1 (en) 1995-12-21
EP0763059B2 (de) 2010-07-28
US6559120B2 (en) 2003-05-06
ES2293641T3 (es) 2008-03-16
US7148019B2 (en) 2006-12-12
US6008340A (en) 1999-12-28
AU2759895A (en) 1996-01-05
DE69535587D1 (de) 2007-10-11
JPH10501417A (ja) 1998-02-10
US20030171567A1 (en) 2003-09-11
EP0763059B1 (de) 2007-08-29
SE9402089D0 (sv) 1994-06-14

Similar Documents

Publication Publication Date Title
ATE371671T1 (de) Rekombinantes allergen, seine fragmente und die damit korrespondierenden dna-moleküle, vektoren, und diese dna-moleküle enthaltenden wirte, und dignostische und therapeutische verwendungen besagter allergene und fragmente
Andreu et al. Solid-phase synthesis of cecropin A and related peptides.
ATE420180T1 (de) Verbindungen zur immuntherapie und diagnose von tuberkulose und methoden zu deren verwendung
DE69735375D1 (de) Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung
KR870700100A (ko) 최소한 일부분이 알려진 뉴클레오티드 암호서열 또는 아미노산 서열을 갖는 프로테인 또는 펩티드에 상보적인 폴리펩티드와 이것의 디자인 방법
PT1672368E (pt) Epítopo de diagnóstico e terapêutico
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
EP1806402A3 (de) CTLA4/CD28 Liganden und deren Anwendungen
CA2289912A1 (en) Human receptor proteins; related reagents and methods
NO995002D0 (no) Modifiserte TNF-<alfa>-molekyler, DNA som koder for slike modifiserte TNF-<alfa>-molekyler og vaksiner omfattende slike TNF-<alfa>-molekyler og DNA
ATE135403T1 (de) Herstellung und reinigung eines proteins, das mit einem bindungsprotein fusioniert ist
TR27970A (tr) Bitki kofulu icine hedeflemede kullanilan yeni sinyal dizimleri.
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
ATE175719T1 (de) Epididymis-spezifische polypeptide und deren verwendung
JP4568842B2 (ja) 熱帯熱マラリア原虫のエノラーゼ蛋白質の部分ペプチドの製造方法
WO2001036476A3 (en) Ing2, an iaps associated cell cycle protein, compositions and methods of use
JPS6460388A (en) Gene coding linked material of protein a-like substance fc bond region, recombinant plasmid containing said gene and transformant produced by using said recombinant plasmid
Kausler et al. Analysis of peptides of human seminal plasma by mass spectrometry
DK1551867T3 (da) Anvendelse af poly-alfa-2,8-sialsyre-mimetiske peptider til modulering af NCAM-funktioner
SE9402090D0 (sv) Recombinent molecules, proteins/polypeptides, host systems and diagnostic and therapeutic methods for atopy
WO2001036474A3 (en) Srik a novel cell cycle protein associated with rip3
WO2001046412A3 (de) Interaktionsprotein für stat transkriptionsfaktor
TH38358A (th) ลำดับกรดนิวคลีอิคและกรดอะมิโนที่เกี่ยวข้องกับHelicobacter pylori สำหรับการวินิจฉัยและรักษา
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
RU99127322A (ru) Белки, связывающиеся с сахарозой

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties